Abstract
Although the physiological decline occurring during aging is much more subtle than that observed in young people and adults with cardiac disease, heart failure (HF) is a disease of the elderly. This may be related to a significant loss of cardiac myocytes occurring through apoptosis; this loss may be secondary to mitochondrial dysfunction, probably caused by chronic exposure to ROS, which will result in damaged mtDNA (mutations and deletions) and mitochondrial membranes. In this chapter, we will discuss clinical aspects of HF in the elderly and define their etiology, pathophysiology, clinical presentation, diagnosis and common approaches to therapeutic interventions, including pharmacotherapy, and device and replacement therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
O’Connell J (2000) The economic burden of heart failure. Clin Cardiol 23:III6–III10
Kannel WB, Belanger AJ (1991) Epidemiology of heart failure. Am Heart J 121:951–957
Anversa P, Rota M, Urbanek K, Hosoda T, Sonnenblick EH, Leri A, Kajstura J, Bolli R (2005) Myocardial aging – a stem cell problem. Basic Res Cardiol 100:482–493
Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:1948–1955
Kitzman DW (2000) Heart failure with normal systolic function. Clin Geriatr Med 16:489–512
Wei JY (1992) Age and the cardiovascular system. N Engl J Med 327:1735–1739
Olivetti G, Melissari M, Capasso JM, Anversa P (1991) Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68:1560–1568
Lakatta EG (2000) Cardiovascular aging in health. Clin Geriatr Med 16:419–444
Van Coster R, Smet J, George E, De Meirleir L et al (2001) Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 50:658–665
Brunt UT, Terman A (2002) The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269:1996–2002
Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF et al (2000) Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35:1628–1637
Ghali JK, Kadakia S, Cooper R, Ferlinz J (1988) Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 148:2013–2016
Tresch DD (2000) Clinical manifestations, diagnostic assessment, and etiology of heart failure in elderly patients. Clin Geriatr Med 16:445–456
Heiat A, Gross CP, Krumholz HM (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162:1682–1688
Incalzi AR, Capparella O, Gemma A, Porcedda P, Raccis G, Sommella L, Carbonin PU (1992) A simple method of recognizing geriatric patients at risk for death and disability. J Am Geriatr Soc 40:34–38
Arnold JM, Liu P, Demers C, Dorian P et al (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22:23–45
Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E, Lo Monaco MR, Cocchi A, Carbonin P, Bernabei R (2003) The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 115:97–103
Kelly KG, Zisselman M, Cutillo-Schmitter T, Reichard R, Payne D, Denman SJ (2001) Severity and course of delirium in medically hospitalized nursing facility residents. Am J Geriatr Psychiatry 9:72–77
Gottlieb SS, Khatta M, Friedmann E, Einbinder L et al (2004) The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43:1542–1549
Joynt KE, Whellan DJ, O’Connor CM (2004) Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 10:258–271
Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9:440–449
Vogels RL, Oosterman JM, van Harten B, Gouw AA, Schroeder-Tanka JM, Scheltens P, van der Flier WM, Weinstein HC (2007) Neuroimaging and correlates of cognitive function among patients with heart failure. Dement Geriatr Cogn Disord 24:418–423
Vogels RL, Oosterman JM, van Harten B, Scheltens P, van der Flier WM, Schroeder-Tanka JM, Weinstein HC (2007) Profile of cognitive impairment in chronic heart failure. J Am Geriatr Soc 55:1764–1770
Cournot M, Leprince P, Destrac S, Ferrieres J (2007) Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure. Am J Geriatr Cardiol 16:8–14
Cournot M, Mourre F, Castel F, Ferrières J, Destrac S (2008) Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure. Am Heart J 155:986–989
Haugen E, Gan LM, Isic A, Skommevik T, Fu M (2008) Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Exp Clin Cardiol 13:19–24
Das A, Abraham S, Deswal A (2008) Advances in the treatment of heart failure with a preserved ejection fraction. Curr Opin Cardiol 23:233–240
Shah R, Wang Y, Foody JM (2008) Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients > or =65 years of age with heart failure and preserved left ventricular systolic function. Am J Cardiol 101:217–222
Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338–2345
Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777–781
Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456–2467
van Veldhuisen DJ, Cohen-Solal A, Bohm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 53:2150–2158
Ahmed A, Kiefe CI, Allman RM, Sims RV, DeLong JF (2002) Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications. J Am Geriatr Soc 50:1659–1666
Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ et al (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225
Hori M, Kitabatake A, Tsutsui H, Okamoto H, Shirato K, Nagai R, Izumi T, Yokoyama H, Yasumura Y, Ishida Y, Matsuzaki M, Oki T, Sekiya M (2005) Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF). J Card Fail 11:542–547
Hagen TM, Moreau R, Suh JH, Visioli F (2002) Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann NY Acad Sci 959:491–507
Tiano L, Fedeli D, Santoni G, Davies I, Wakabayashi T, Falcioni G (2003) Ebselen prevents mitochondrial ageing due to oxidative stress: in vitro study of fish erythrocytes. Mitochondrion 2:428–436
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289:1107–1116
Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y (2000) Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 34:427–432
Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R et al (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360:1631–1639
Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F (2004) The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 25:1570–1595
Alehagen U, Rahmqvist M, Paulsson T (2008) Levin LA.Quality-adjusted life year weights among elderly patients with heart failure. Eur J Heart Fail 10:1033–1039
Bleeker GB, Schalij MJ, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Bax JJ (2005) Comparison of effectiveness of cardiac resynchronization therapy in patients <70 versus > or =70 years of age. Am J Cardiol 96:420–422
Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM (2008) Clinical response of cardiac resynchronization therapy in the elderly. Am Heart J 155:746–751
Piccini JP, Hernandez AF, Dai D, Thomas KL, Lewis WR, Yancy CW, Peterson ED, Fonarow GC; Get With the Guidelines Steering Committee and Hospitals (2008) Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation 118:926–933
McAlister FA (2008) Cardiac resynchronization therapy for heart failure: a hammer in search of nails. Circulation 118:901–903
Morgan JA, John R, Weinberg AD, Remoli R et al (2003) Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 76:1982–1987
Zuckermann A, Dunkler D, Deviatko E, Bodhjalian A, Czerny M, Ankersmit J, Wolner E, Grimm M (2003) Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Eur J Cardiothorac Surg 24:283–291
Potapov EV, Loebe M, Hubler M, Musci M, Hummel M, Weng Y, Hetzer R (1999) Medium-term results of heart transplantation using donors over 63 years of age. Transplantation 68:1834–1838
Blanche C, Kamlot A, Blanche DA, Kearney B, Magliato KE, Czer LS, Trento A (2002) Heart transplantation with donors fifty years of age and older. J Thorac Cardiovasc Surg 123:810–815
Morgan JA, John R, Weinberg AD, Remoli R, Kherani AR, Vigilance DW, Schanzer BM, Bisleri G, Mancini DM, Oz MC, Edwards NM (2003) Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 76:1982–1987
Marelli D, Kobashigawa J, Hamilton MA, Moriguchi JD, Kermani R, Ardehali A, Patel J, Noguchi E, Beygui R, Laks H, Plunkett M, Shemin R, Esmailian F (2008) Long-term outcomes of heart transplantation in older recipients. J Heart Lung Transplant 27:830–834
Weiss ES, Nwakanma LU, Patel ND, Yuh DD (2008) Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 27:184–191
Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A et al (2000) Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 355:1575–1581
Richardson LG, Rocks M (2001) Women and heart failure. Heart Lung 30:87–97
McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marín-García, J. (2010). Heart Failure of Aging: Clinical Considerations. In: Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-147-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-60761-147-9_17
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-146-2
Online ISBN: 978-1-60761-147-9
eBook Packages: MedicineMedicine (R0)